Holen Sie sich die Stockscreener-App
0.9951
9.83%
-0.1049
Caribou Biosciences Inc Aktie (CRBU) Neueste Nachrichten
Anti-CD152 Antibody Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | Precision Biosciences, TG Therapeutics, RemeGen, Caribou Biosciences - Barchart.com
Shareholders that lost money on Caribou Biosciences, Inc.(CRBU) should contact Levi & Korsinsky about pending Class ActionCRBU - ACCESS Newswire
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates - MSN
Brokerages Set Caribou Biosciences, Inc. (NASDAQ:CRBU) Price Target at $9.33 - Defense World
Cantor Fitzgerald Analysts Lower Earnings Estimates for CRBU - Defense World
Dimensional Fund Advisors LP Sells 321,867 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Caribou Biosciences (CRBU) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Barclays PLC Grows Stock Holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Caribou Biosciences Reports Q1 2025 Financial Results - TipRanks
Investors in Caribou Biosciences, Inc. Should Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your RightsCRBU - ACCESS Newswire
Investors who lost money on Caribou Biosciences, Inc.(CRBU) should contact Levi & Korsinsky about pending Class ActionCRBU - ACCESS Newswire
Caribou Biosciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your RightsCRBU - ACCESS Newswire
Caribou Biosciences (CRBU) Receives a Buy from Bank of America Securities - The Globe and Mail
Shareholders that Lost Money on Caribou Biosciences, Inc. (CRBU) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
RBC Lowers Price Target on Caribou Biosciences to $10 From $11, Keeps Outperform, Speculative Risk - marketscreener.com
Envestnet Asset Management Inc. Grows Stake in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Caribou Biosciences earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Comparing Invizyne Technologies (NASDAQ:IZTC) and Caribou Biosciences (NASDAQ:CRBU) - Defense World
Ratio Revelations: Caribou Biosciences Inc (CRBU)’s Financial Metrics in the Spotlight - DWinneX
Leading CRISPR Company Caribou Biosciences to Reveal Latest Pipeline Updates at Major Healthcare Conference - Stock Titan
Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference - The Manila Times
Caribou Biosciences (CRBU) to Release Quarterly Earnings on Tuesday - Defense World
Levi & Korsinsky Notifies Shareholders of Caribou Biosciences, Inc.(CRBU) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Investors Can Still File Late Claims for Caribou Biosciences $3.9M Settlement Payouts - TradingView
HC Wainwright Issues Optimistic Forecast for CRBU Earnings - Defense World
Caribou Biosciences Inc [CRBU] Records 200-Day SMA of $1.6979 - knoxdaily.com
Taking the lead: Caribou Biosciences Inc (CRBU) - Sete News
Caribou Biosciences Investors Drop Suit Over Cell Therapy, Cash - Bloomberg Law News
CRBU Deadline: CRBU Investors Have Opportunity to Lead Caribou B - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
Is Caribou Biosciences Inc (CRBU) worth investing in despite its undervalued state? - uspostnews.com
Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should Know - Yahoo
Caribou Biosciences Inc (NASDAQ: CRBU) -0.30% Decline Turns Investors Away - Stocksregister
Geode Capital Management LLC Sells 58,048 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
H.C. Wainwright cuts Caribou Biosciences stock target to $3 By Investing.com - Investing.com India
H.C. Wainwright cuts Caribou Biosciences stock target to $3 - Investing.com Australia
Caribou Biosciences (CRBU) Target Price Cut Amid Strategic Shift - GuruFocus
Quarterly Snapshot: Quick and Current Ratios for Caribou Biosciences Inc (CRBU) - DWinneX
Caribou Biosciences Inc (CRBU) Stock: A Year of Decreases and Increases - investchronicle.com
Caribou Biosciences Inc (CRBU) receives an In-line rating from Evercore ISI - knoxdaily.com
Caribou Biosciences (CRBU) Target Price Cut Amid Strategic Shift | CRBU Stock News - GuruFocus
Caribou Biosciences (CRBU) Sees Price Target Cut Amid Strategic - GuruFocus
Russell Investments Group Ltd. Boosts Holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Lost Money on Caribou Biosciences, Inc. (CRBU)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
CRISPR Biotech Caribou Trims Pipeline and Cuts 32% of Staff to Focus on Two Cancer Cell Therapies - MedCity News
Caribou Biosciences (CRBU) Restructures, Focuses on Key Oncology Programs - GuruFocus
0.76%
2.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):